Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product Jan 14, 2022
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted… Jan 13, 2022
